Advanced Genomics – Key Disruptive Forces to Transform Health and Wellness
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Advances in genomics have revolutionized approaches to healthcare and precision medicine. The major drivers of genomics include personalized medicine, customized genetic counseling, genetic predisposition identification, accurate disease diagnosis, disease prevention, and optimized treatments.
Advances in genomics are significantly reducing the cost of genome sequencing. Genomic techniques not only help in understanding the nature of the virus to trace its potential origins but also aids in tracking disease outbreaks.
The Advanced Genomics FutureTech Series report categorizes 30+ disruptive forces in genomics as emerging, accelerating, and maturing innovation areas based on their rate of growth in innovation. It also casts light on key market activities in emerging innovation areas, such as Chimeric antigen receptor (CAR-T) cell therapy, nanopore sequencing, comparative genomic hybridization (CGH), and genetic data encryption on the patent grants, key geographies, major players, and recent developments.
Key Sectors Impacted by Genomics
Some of the key sectors in genomics by the news, deals and company filings are healthcare, technology, media & telecom, government & non-profit organizations, consumer, agriculture & forestry, chemicals, and financial services.
Innovation Area Definitions and Patent Trends
Emerging: Single-molecule real-time (SMRT) sequencing is a technology that enables sequencing from individual DNA molecules without the need for amplification and fragmentation of the target sequence.
Accelerating: Mutation tracking is the process of detecting any alteration in the nucleic acid sequence of the genome of an organism that may or may not alter the phenotype.
Maturing: Herbicide resistant crops (HRC) are designed to tolerate specific broad-spectrum herbicides, which can kill the surrounding weeds but leave the cultivated crop intact.
Emerging, Accelerating, and Maturing Innovation Areas with Disruptive Potential in Genomics
For more innovation area insights, download a free report sample
Emerging Innovation Areas in Genomics
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Non-Coding DNA/RNA Therapy
- Comparative Genomic Hybridization (CGH)
- Nanoball Sequencing
- Single Molecule Sequencing
- Chimeric Antigen Receptor (CAR-T) Cell Therapy
- Genetic Data Encryption
Advanced Genomics FutureTech Series Report Overview
Key Sectors | Healthcare, Technology, Media & Telecom, Government & Non-Profit Organizations, Consumer, Agriculture & Forestry, Chemicals, and Financial Services |
Major Drivers | Personalized Medicine, Customized Genetic Counseling, Genetic Predisposition Identification, Accurate Disease Diagnosis, Disease Prevention, and Optimized Treatments |
Emerging Innovation Areas | Nanopore Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Non-Coding DNA/RNA Therapy, Comparative Genomic Hybridization (CGH), Nanoball Sequencing, Single Molecule Sequencing, Chimeric Antigen Receptor (CAR-T) Cell Therapy, and Genetic Data Encryption |
Scope
- Key disruptive forces in genomics – presents the major drivers, impact, top sectors impacted by genomics, and emerging, accelerating, and maturing innovation areas with disruptive potential in genomics.
- Emerging innovation areas – overview of select emerging innovation areas to capture their disruptive potential, innovation drivers, recent developments, patents trends, partnerships, and disruptive startups.
- Outlook – Genomics technology innovation intensity (TII) forecast till 2025 vs an average of 35 trending technologies.
Reasons to Buy
GlobalData’s FutureTech Series Reports are aimed at capturing futuristic technologies which have the potential to disrupt tomorrow. These technologies are constantly changing, adapting, and progressing to enable a paradigm shift in our daily lives. The awareness, knowledge, and expertise of these topics help transform business models and strategic thinking with an in-depth understanding of megatrends that can directly influence patenting, collaboration, acquisition, and investment decisions.
Access
Adaptive Biotechnologies
Agilent Technologies
Annogen
Ascus Bioscience
Bayer
BGI Group
BioNTech
bluebird bio
Bluestar Genomics
BostonGene
Caribou Biosciences
CD Genomics
CHUV
Codexis
Congenica
Corteva
CRISPR Therapeutics
Dovetail Genomics
Editas Medicine
EXUMA Biotech
GeneCrypt
Genemind
Genetica
Genomics England
GenomSys
Gritstone Bio
Guardant Health
Hamad Bin Khalifa University
HAYA Therapeutics
Helix OpCo
Human Longevity
IBM
Ideaya Biosciences
iLAC
Illumina
Immatics
Inbiomotion
Intellia Therapeutics
Johnson & Johnson
JumpCode Genomics
KeyGene
LabCorp
Legend Biotech
Macrogen
Mayo Clinic
MS Technologies
NantWorks
Natera
Novartis
Oncorus
Otsuka
Oxford Nanopore Technologies
PacBio
PathogenDx
Personalis
Philips
Precision Biosciences
ProKidney
Quantum-Si
Ravel
Recombinetics
Regeneron Pharmaceuticals
Robotic Biology Institute
Roche
Roswell Biotechnologies
Roswell Biotechnologies
Sangamo Therapeutics
Seqll
Seven Bridges Genomics
SNIPR Biome
SOHO Global Health
Sophia Genetics
Stoke Therapeutics
The Bristol-Myers Squibb
Thermo Fisher Scientific
TwinStrand Biosciences
Unitec
XenoTherapeutics
Table of Contents
Frequently asked questions
-
What are the major drivers of genomics?
The major drivers of genomics include personalized medicine, customized genetic counseling, genetic predisposition identification, accurate disease diagnosis, disease prevention, and optimized treatments.
-
What is Single-Molecule Real-Time (SMRT) Sequencing?
Single-molecule real-time (SMRT) sequencing is a technology that enables sequencing from individual DNA molecules without the need for amplification and fragmentation of the target sequence.
-
What are some of the key sectors that have been impacted by genomics?
Some of the key sectors in genomics by the news, deals and company filings are healthcare, technology, media & telecom, government & non-profit organizations, consumer, agriculture & forestry, chemicals, and financial services.
-
What are the emerging innovation areas in genomics?
The emerging innovation areas in genomics are nanopore sequencing, single-molecule real-time (SMRT) sequencing, non-coding DNA/RNA therapy, comparative genomic hybridization (CGH), nanoball sequencing, single molecule sequencing, chimeric antigen receptor (CAR-T) cell therapy, and genetic data encryption.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.